
Quantitative G6PD Deficiency Screening in Routine Malaria Diagnostic Units in the Brazilian Amazon (SAFEPRIM): An Operational Mixed-Methods Study
2022; Multidisciplinary Digital Publishing Institute; Volume: 11; Issue: 11 Linguagem: Inglês
10.3390/pathogens11111328
ISSN2076-0817
AutoresJosé Diego Brito-Sousa, Felipe Murta, Sheila Vítor-Silva, Vanderson de Souza Sampaio, Maxwell O. Mendes, Brenda K. A. Souza, Talita S. B. Batista, Alícia Cacau Santos, Leonardo Lincoln Gomes Marques, Laila R. A. Barbosa, Patrícia Carvalho da Silva Balieiro, Alexandre Vilhena Silva-Neto, Renata dos Santos Rabello, Marcelo Augusto Mota Brito, Emanuelle Silva, Sheila Rodovalho, Ana Ruth Lima Arcanjo, Gisely Cardoso de Melo, Judith Recht, Gonzalo J. Domingo, Suiane Costa Negreiros do Valle, Rodrigo Medeiros de Souza, Theresa Helissa Nakagawa, Wuelton Marcelo Monteiro, Marcus Lacerda,
Tópico(s)Methemoglobinemia and Tumor Lysis Syndrome
ResumoGlucose-6-phosphate dehydrogenase (G6PD) deficiency testing is not routinely performed before primaquine treatment in most
Referência(s)